SpyGlass Pharma, co-founded by Dr. Malik Y. Kahook, MD, and Glenn Sussman, is dedicated to developing innovative treatments for chronic ophthalmic diseases. The company is built upon technology initially developed at the Sue Anschutz-Rodgers Eye Center of the University of Colorado School of Medicine. With a team comprising skilled engineers, scientists, and clinicians, SpyGlass Pharma focuses on creating transformative treatm...
SpyGlass Pharma, co-founded by Dr. Malik Y. Kahook, MD, and Glenn Sussman, is dedicated to developing innovative treatments for chronic ophthalmic diseases. The company is built upon technology initially developed at the Sue Anschutz-Rodgers Eye Center of the University of Colorado School of Medicine. With a team comprising skilled engineers, scientists, and clinicians, SpyGlass Pharma focuses on creating transformative treatment options for patients with ophthalmic diseases. Their primary objective is to achieve long-term drug delivery solutions.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.